Invention Grant
US07671057B2 Therapeutic agent for type II diabetes comprising protease-inhibiting compound
失效
包含蛋白酶抑制化合物的II型糖尿病治疗剂
- Patent Title: Therapeutic agent for type II diabetes comprising protease-inhibiting compound
- Patent Title (中): 包含蛋白酶抑制化合物的II型糖尿病治疗剂
-
Application No.: US11667099Application Date: 2005-11-07
-
Publication No.: US07671057B2Publication Date: 2010-03-02
- Inventor: Yoshiki Sakai
- Applicant: Yoshiki Sakai
- Applicant Address: JP Osaka
- Assignee: Ono Pharmaceutical Co., Ltd.
- Current Assignee: Ono Pharmaceutical Co., Ltd.
- Current Assignee Address: JP Osaka
- Agency: Wenderoth, Lind & Ponack, L.L.P.
- Priority: JP2004-323188 20041108; JP2005-129673 20050427
- International Application: PCT/JP2005/020380 WO 20051107
- International Announcement: WO2006/057152 WO 20060601
- Main IPC: A61K31/496
- IPC: A61K31/496 ; A61K31/50 ; A61K31/445 ; A61K31/235
Abstract:
The problem of the present invention is to provide a preventive and/or therapeutic agent for diabetes and/or complications of diabetes based on the novel mode of action.The protease-inhibiting compound according to the present invention is a compound represented by the general formula (I) [wherein all the symbols have the same meanings as described in the specification], its salt or solvate, or a prodrug thereof, is useful as a preventive and/or therapeutic agent for diabetes and/or complications of diabetes.
Public/Granted literature
- US20080009537A1 Therapeutic Agent for Diabetes Comprising Protease-Inhibiting Compound Public/Granted day:2008-01-10
Information query
IPC分类:
